Promotional material from the Boehringer Ingelheim and Lilly Alliance
The production of this Guidelines summary card has been commissioned by the Boehringer Ingelheim and Lilly Alliance.
View Jardiance® (empagliflozin) prescribing and adverse event reporting information for Great Britain and Northern Ireland.
Date of preparation: November 2021
If you are a UK-based doctor, nurse, or pharmacist, you must sign in to your account or register (for free) if you do not already have one.
Return to homepage
Site powered by Webvision Cloud